Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IB1001 Pharmacokinetic and Outcome Study in Hemophilia B
NCT00768287Phase 3Completed
- Sponsor
- Medexus Pharmaceuticals
- Start
- Jan 2009
- Primary completion
- Mar 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of trenonacog alfa in hemophilia B (HB), sponsored by Medexus Pharmaceuticals. Started Jan 2009; status: completed.
02
Drugs
trenonacog alfa
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT00768287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768287.